Spectacle Lenses With Highly Aspherical Lenslets for Myopia Control: A Randomized Clinical Trial - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Randomized Clinical Trial of Highly Aspherical Lenslet Spectacle Lenses for Myopia Control

  • By

  • Jason Shen

  • Chris Hunt

  • Graeme Young

  • Björn Drobe

  • October 1, 2026

Share

  • 1

    This multicenter US randomized clinical trial compared highly aspherical lenslet (HAL) spectacles with single-vision lenses in children aged 6 to 12 years with myopia.

  • 2

    The trial was double-masked, randomized participants 1:1, and stratified assignment by site, age group, and baseline myopia severity.

  • 3

    The prespecified 24-month analysis assessed changes from baseline in cycloplegic spherical equivalent refraction and axial length; the trial’s primary end point is at 36 months.

  • 4

    HAL lenses combine a single-vision correction zone with 11 contiguous rings of highly aspherical lenslets designed to create myopic defocus anterior to the retina.

  • 5

    The study assessed safety through adverse events, visual acuity, and symptoms, problems, and complaints, and instructed participants to wear study spectacles at least 10 hours daily on 6 days each wee

Original Source(s)

Related Content